UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Prediction of malignant lymph nodes in NSCLC by machine-learning classifiers using EBUS-TBNA and PET/CT

Scientific reports, 2022-10, Vol.12 (1), p.17511-17511, Article 17511

2022

Volltextzugriff (PDF)

C-reactive protein as robust laboratory value associated with prognosis in patients with stage III non-small cell lung cancer (NSCLC) treated with definitive radiochemotherapy

Scientific reports, 2024-06, Vol.14 (1), p.13765-12

2024

Volltextzugriff (PDF)

Impact of metallothionein-knockdown on cisplatin resistance in malignant pleural mesothelioma

Scientific reports, 2020-10, Vol.10 (1), p.18677, Article 18677

2020

Volltextzugriff (PDF)

Gene expression profiling of homologous recombination repair pathway indicates susceptibility for olaparib treatment in malignant pleural mesothelioma in vitro

BMC cancer, 2019-01, Vol.19 (1), p.108-12, Article 108

2019

Volltextzugriff (PDF)

Machine learning reveals a PD-L1–independent prediction of response to immunotherapy of non-small cell lung cancer by gene expression context

European journal of cancer (1990), 2020-11, Vol.140, p.76-85

2020

Volltextzugriff (PDF)

DNA methylation of PTGER4 in peripheral blood plasma helps to distinguish between lung cancer, benign pulmonary nodules and chronic obstructive pulmonary disease patients

European journal of cancer (1990), 2021-04, Vol.147, p.142-150

2021

Volltextzugriff (PDF)

Long-term survival of patients with central or > 7 cm T4 N0/1 M0 non-small-cell lung cancer treated with definitive concurrent radiochemotherapy in comparison to trimodality treatment

Radiation oncology (London, England), 2022-07, Vol.17 (1), p.126-14, Article 126

2022

Volltextzugriff (PDF)

Treatment decisions, clinical outcomes, and pharmacoeconomics in the treatment of patients with EGFR mutated stage III/IV NSCLC in Germany: an observational study

BMC cancer, 2018-02, Vol.18 (1), p.135-135, Article 135

2018

Volltextzugriff (PDF)

Long-Term Survival in Patients with Oligometastatic Non-Small Cell Lung Cancer by a Multimodality Treatment-Comparison with Stage III Disease

Cancers, 2024-03, Vol.16 (6), p.1174

2024

Volltextzugriff (PDF)

68Ga-SSO-120 PET for Initial Staging of Small Cell Lung Cancer Patients: A Single-Center Retrospective Study

The Journal of nuclear medicine (1978), 2023-10, Vol.64 (10), p.1540-1549

2023

Volltextzugriff (PDF)

Neoadjuvant and adjuvant end-points in health technology assessment in oncology

European journal of cancer (1990), 2021-04, Vol.147, p.40-50

2021

Volltextzugriff (PDF)

MET Expression in Advanced Non–Small-Cell Lung Cancer: Effect on Clinical Outcomes of Chemotherapy, Targeted Therapy, and Immunotherapy

Clinical lung cancer, 2018-07, Vol.19 (4), p.e441-e463

2018

Volltextzugriff (PDF)

The IASLC Lung Cancer Staging Project: Proposals for the Revision of the M Descriptors in the Forthcoming Eighth Edition of the TNM Classification of Lung Cancer

Journal of thoracic oncology, 2015-11, Vol.10 (11), p.1515-1522

2015

Volltextzugriff (PDF)

Epidermal Growth Factor Receptor Inhibition in Lung Cancer: Status 2012

Journal of thoracic oncology, 2013-03, Vol.8 (3), p.373-384

2013

Volltextzugriff (PDF)

History Can Teach Us Something: Angiogenesis Inhibition Revisited

Journal of thoracic oncology, 2024-06, Vol.19 (6), p.849-851

2024

Volltextzugriff (PDF)

Patterns of nodal spread in stage III NSCLC: importance of EBUS-TBNA and 18F-FDG PET/CT for radiotherapy target volume definition

Radiation oncology (London, England), 2021-09, Vol.16 (1), p.1-176, Article 176

2021

Volltextzugriff (PDF)

Inhibiting the Aurora B Kinase Potently Suppresses Repopulation During Fractionated Irradiation of Human Lung Cancer Cell Lines

International journal of radiation oncology, biology, physics, 2012-10, Vol.84 (2), p.492-499

2012

Volltextzugriff (PDF)

Too Good to be True?

Journal of thoracic oncology, 2021-04, Vol.16 (4), p.507-508

2021

Volltextzugriff (PDF)

KRAS G12C-mutated advanced non-small cell lung cancer: A real-world cohort from the German prospective, observational, nation-wide CRISP Registry (AIO-TRK-0315)

Lung cancer (Amsterdam, Netherlands), 2021-04, Vol.154, p.51-61

2021

Volltextzugriff (PDF)

N-staging in large cell neuroendocrine carcinoma of the lung: diagnostic value of [18F]FDG PET/CT compared to the histopathology reference standard

EJNMMI research, 2021-07, Vol.11 (1), p.68-68, Article 68

2021

Volltextzugriff (PDF)

Neutrophils Activate Tumoral CORTACTIN to Enhance Progression of Orohypopharynx Carcinoma

Frontiers in immunology, 2013-01, Vol.4, p.33-33

2013

Volltextzugriff (PDF)

The International Association for the Study of Lung Cancer Staging Project for Lung Cancer: Proposals for the Revision of the M Descriptors in the Forthcoming Ninth Edition of the TNM Classification for Lung Cancer

Journal of thoracic oncology, 2024-05, Vol.19 (5), p.786-802

2024

Volltextzugriff (PDF)

High Prevalence of Concomitant Oncogene Mutations in Prospectively Identified Patients with ROS1-Positive Metastatic Lung Cancer

Journal of thoracic oncology, 2017-01, Vol.12 (1), p.54-64

2017

Volltextzugriff (PDF)

Multimodal treatment of non-small-cell lung cancer

The Lancet (British edition), 2015-09, Vol.386 (9998), p.1018-1020

2015

Volltextzugriff (PDF)

1 – 25 von 104

Suche als RSS-Feed

Aktive Filter

ThemaCarcinoma, Non-Small-Cell Lung - Drug Therapy

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(98)
Mit Volltextzugriff
(99)

Publikationsform

Artikel
(103)
Tagungsberichte
(1)

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(74)
Life Sciences & Biomedicine
(71)
Oncology
(64)
Humans
(57)
Respiratory System
(35)
Lung Neoplasms - Pathology
(33)
Lung Cancer
(28)
Female
(26)
Male
(26)
Neoplasm Staging
(26)
Prognosis
(22)
Middle Aged
(21)
Aged
(20)
Tumors
(17)
Adult
(16)
Carcinoma, Non-Small-Cell Lung - Pathology
(15)
Aged, 80 And Over
(13)
Lung Neoplasms - Therapy
(13)
Carcinoma, Non-Small-Cell Lung - Therapy
(11)
Lung Neoplasms - Classification
(11)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Vorinostat in patients with advanced malignant pleural mesothelioma who have progressed on previous chemotherapy (VANTAGE-014): a phase 3, double-blind, randomised, placebo-controlled trial

Prediction of malignant lymph nodes in NSCLC by machine-learning classifiers using EBUS-TBNA and PET/CT

C-reactive protein as robust laboratory value associated with prognosis in patients with stage III non-small cell lung cancer (NSCLC) treated with definitive radiochemotherapy

Impact of metallothionein-knockdown on cisplatin resistance in malignant pleural mesothelioma

Gene expression profiling of homologous recombination repair pathway indicates susceptibility for olaparib treatment in malignant pleural mesothelioma in vitro

Machine learning reveals a PD-L1–independent prediction of response to immunotherapy of non-small cell lung cancer by gene expression context

DNA methylation of PTGER4 in peripheral blood plasma helps to distinguish between lung cancer, benign pulmonary nodules and chronic obstructive pulmonary disease patients

Long-term survival of patients with central or > 7 cm T4 N0/1 M0 non-small-cell lung cancer treated with definitive concurrent radiochemotherapy in comparison to trimodality treatment

Treatment decisions, clinical outcomes, and pharmacoeconomics in the treatment of patients with EGFR mutated stage III/IV NSCLC in Germany: an observational study

Long-Term Survival in Patients with Oligometastatic Non-Small Cell Lung Cancer by a Multimodality Treatment-Comparison with Stage III Disease

68Ga-SSO-120 PET for Initial Staging of Small Cell Lung Cancer Patients: A Single-Center Retrospective Study

Neoadjuvant and adjuvant end-points in health technology assessment in oncology

MET Expression in Advanced Non–Small-Cell Lung Cancer: Effect on Clinical Outcomes of Chemotherapy, Targeted Therapy, and Immunotherapy

The IASLC Lung Cancer Staging Project: Proposals for the Revision of the M Descriptors in the Forthcoming Eighth Edition of the TNM Classification of Lung Cancer

Epidermal Growth Factor Receptor Inhibition in Lung Cancer: Status 2012

History Can Teach Us Something: Angiogenesis Inhibition Revisited

Patterns of nodal spread in stage III NSCLC: importance of EBUS-TBNA and 18F-FDG PET/CT for radiotherapy target volume definition

Inhibiting the Aurora B Kinase Potently Suppresses Repopulation During Fractionated Irradiation of Human Lung Cancer Cell Lines

Too Good to be True?

KRAS G12C-mutated advanced non-small cell lung cancer: A real-world cohort from the German prospective, observational, nation-wide CRISP Registry (AIO-TRK-0315)

N-staging in large cell neuroendocrine carcinoma of the lung: diagnostic value of [18F]FDG PET/CT compared to the histopathology reference standard

Neutrophils Activate Tumoral CORTACTIN to Enhance Progression of Orohypopharynx Carcinoma

The International Association for the Study of Lung Cancer Staging Project for Lung Cancer: Proposals for the Revision of the M Descriptors in the Forthcoming Ninth Edition of the TNM Classification for Lung Cancer

High Prevalence of Concomitant Oncogene Mutations in Prospectively Identified Patients with ROS1-Positive Metastatic Lung Cancer

Multimodal treatment of non-small-cell lung cancer

Aktive Filter

Suchergebnisse filtern